Fructose diphosphate sodium tablets

This product is a cell metabolite existing in the human body, which can regulate the activity of multiple enzyme systems in glucose metabolism. It is reported that exogenous sodium fructose diphosphate can increase the concentration of adenosine triphosphate and creatine phosphate in cells by activating the activity of phosphofructokinase and pyruvate kinase, promote the influx of potassium ions, and is beneficial to the energy metabolism and glucose utilization of cells under ischemic and hypoxic conditions, thereby reducing damage to ischemic myocardium.

Fructose-1,6-diphosphate sodium salt. Chemical name: 1,6-diphosphate fructose tricalcium salt Molecular weight: C6H11Na3O12P2

This product is a film-coated tablet, which appears white or off-white after removing the film coating.

Used as an auxiliary treatment for myocardial ischemia, angina pectoris and cerebral infarction.

Oral administration, 1g (4 tablets) at a time, 3 times a day, or as directed by a physician.

The main manifestations are mild symptoms of the digestive system, such as abdominal distension, nausea, upper abdominal burning sensation, loose stools, etc. Patients can generally tolerate it and there is no need to stop the medication.

It is contraindicated for patients who are allergic to this product, have hyperphosphatemia, severe renal insufficiency, heart failure, and edema.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Not yet clear.

Sealed and stored in a cool place.

0.25g (based on C6H11Na3O12P2)

18 months

Shanghai Sine Tianping Pharmaceutical Co., Ltd.

• Founded in:

  1998-05-07

• Address:

  No. 4598, Jindu Road, Minhang District, Shanghai

• Tax NO.:

  91310112832231856K

• Registered Funds:

  154.7 million yuan

• Email:

  Log in to view